BridgeBio Pharma (BBIO) Inventory (2025 - 2026)
BridgeBio Pharma (BBIO) reported Inventory of $33.0 million for Q1 2026, up 734.09% on a YoY basis from $4.0 million in Q1 2025, and up 23.28% sequentially from $26.8 million in Q4 2025.
BridgeBio Pharma (BBIO) Inventory (2025 - 2026) Analysis & Trends
BridgeBio Pharma (BBIO) has 2 years of Inventory data on file, last reported at $33.0 million in Q1 2026.
- For the quarter ending Q1 2026, Inventory rose 734.09% year-over-year to $33.0 million; the trailing twelve-month figure through Mar 2026 stood at $33.0 million (up 734.09% YoY), and the FY2025 full-year result was $26.8 million, changed N/A from the prior year.
- Inventory rose to $33.0 million in Q1 2026, from $26.8 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $33.0 million in Q1 2026 to a low of $4.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 681.59 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.77 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.10 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 371.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | BridgeBio Pharma | 16.15 Bn | 15.22 Bn | 184.58 Mn | 32.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.98 Mn |
| Dec 31, 2025 | 26.75 Mn |
| Sep 30, 2025 | 24.53 Mn |
| Jun 30, 2025 | 18.28 Mn |
| Mar 31, 2025 | 3.95 Mn |